Chinese Journal of Dermatology ›› 2024, Vol. 57 ›› Issue (5): 462-463.doi: 10.35541/cjd.20210557

• Case Reports • Previous Articles     Next Articles

Anlotinib for the treatment of a case of cutaneous angiosarcoma

Chen Huyan1, Wang Lei2, Liu Yiwen3, Zhou Junhao3, Cao Lei3   

  1. 1Department of Dermatology, Huashan Hospital, Fudan University, Shanghai 200040, China; 2Department of Dermatology, the Affiliated Wuxi People′s Hospital of Nanjing Medical University, Wuxi 214000, Jiangsu, China; 3Department of Dermatology, the Affiliated Wuxi No.2 People′s Hospital of Nanjing Medical University, Wuxi 214000, Jiangsu, China
  • Received:2021-08-02 Revised:2022-02-16 Online:2024-05-15 Published:2024-04-30
  • Contact: Cao Lei E-mail:caolei_lei@sina.com
  • Supported by:
    Natural Science Foundation of Jiangsu Province of China （BK20180165）; Wuxi Science and Technology Development Fund Project （Y20212027）

PDF

5

PDF (Mobile)

0

Key words: cutaneous angiosarcoma, anlotinib

share this article

0
    /   /   Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://www.pifukezazhi.com/EN/10.35541/cjd.20210557

         http://www.pifukezazhi.com/EN/Y2024/V57/I5/462